Yes I think that managemt been terrible more because they did not communicate prior to the stopclock that the adequacy of their trial was in question!! I would never have taken up the 21cent offer knowing this!!
Next I can't sell at this price - too low and too big a loss.
IGF-1 has been used for years in humans so I dont understand what more information they could want? Perhaps a quick animal or lab study testing the stability on a wound with vitronectin??? Less than 6 months for results would make me happy.
Another human trial to look at its efficacy? I thought that wasn't needed for a CE mark? Especially with a known product?
Otherwise next stop 2 years for FDA and CE mark along with dilution...hope not. All in my opinion only..
After May we will get much more info on timelines, costs, and the future. That may bring more stability to the share price.... If they communicate with us...
TIS Price at posting:
9.4¢ Sentiment: Buy Disclosure: Held
